TY - JOUR
T1 - Standardization of In-Vitro Evaluation of Extracorporeal Life Support (ECLS) Devices for Research and Development
AU - Arens, Jutta
AU - Belliato, Mirko
AU - Broman, Lars Mikael
AU - Clauser, Johanna C.
AU - Donker, Dirk W.
AU - Lorusso, Roberto
AU - Malfertheiner, Maximilian
AU - Rajsic, Sasa
AU - Swol, Justyna
AU - Vercaemst, Leen
AU - Prahl Wittberg, Lisa
AU - Di Nardo, Matteo
AU - Donker, Dirk
AU - Grazioli, Lorenzo
AU - Heinze, Johannes
AU - Menne, Matthias
AU - Schlotterhose, Lena
AU - Steuer, Niklas
AU - Haumann, Renard
AU - Hübler, Michael
AU - Kalfa, David
AU - Lesbekov, Timur
AU - Schlöglhofer, Thomas
AU - Tucanova, Zuzana
AU - Vincentelli, André
AU - ECLS & MCS and the EuroELSO Innovation Group
AU - EACTS Innovation Committee, Section CPB
N1 - Publisher Copyright:
This article is published jointly in the ASAIO Journal, Artificial Organs, Interdisciplinary CardioVascular and Thoracic Surgery, and Perfusion under a co-publishing agreement. The Authors retain copyright © 2026.
PY - 2026/7
Y1 - 2026/7
N2 - Extracorporeal life support (ECLS) technology has witnessed remarkable advancements during the last decades. However, further research and development of devices are required to increase, for example, performance-efficiency, hemocompatibility, and long-term stability. All novel devices, even in early research stages, must undergo rigorous testing and evaluation. Yet, these early evaluations are often conducted under nonstandardized conditions, resulting in data difficult to compare, interpret, or translate into clinical practice. Establishing well-defined, standardized in-vitro testing protocols for all ECLS components and devices would represent a major step forward. Such protocols would improve methodological consistency and ensure reproducibility across research groups. This document, developed by an international group of ECLS experts from all disciplines in which such components are designed, developed, and applied, provides clear recommendations and standardized criteria for device testing according to international norms. Adoption of these criteria including the ways of reporting results will foster a unified approach among scientists, engineers, clinicians, and the medical device industry. Ultimately, this common framework will facilitate data interpretation, improve comparability of study results between different groups, making the review of studies more straightforward, as not every aspect of testing requires additional review and discussion, certainly favoring decision-making in the development and application of ECLS technologies.
AB - Extracorporeal life support (ECLS) technology has witnessed remarkable advancements during the last decades. However, further research and development of devices are required to increase, for example, performance-efficiency, hemocompatibility, and long-term stability. All novel devices, even in early research stages, must undergo rigorous testing and evaluation. Yet, these early evaluations are often conducted under nonstandardized conditions, resulting in data difficult to compare, interpret, or translate into clinical practice. Establishing well-defined, standardized in-vitro testing protocols for all ECLS components and devices would represent a major step forward. Such protocols would improve methodological consistency and ensure reproducibility across research groups. This document, developed by an international group of ECLS experts from all disciplines in which such components are designed, developed, and applied, provides clear recommendations and standardized criteria for device testing according to international norms. Adoption of these criteria including the ways of reporting results will foster a unified approach among scientists, engineers, clinicians, and the medical device industry. Ultimately, this common framework will facilitate data interpretation, improve comparability of study results between different groups, making the review of studies more straightforward, as not every aspect of testing requires additional review and discussion, certainly favoring decision-making in the development and application of ECLS technologies.
KW - blood cell damage
KW - cannula
KW - ECLS
KW - ECMO
KW - extracorporeal life support
KW - extracorporeal membrane oxygenation
KW - in-vitro testing
KW - oxygenator
KW - pump
KW - standardization
KW - tubing
U2 - 10.1097/MAT.0000000000002623
DO - 10.1097/MAT.0000000000002623
M3 - Article
SN - 1058-2916
VL - 72
SP - 525
EP - 538
JO - Asaio Journal
JF - Asaio Journal
IS - 7
M1 - 10.1097/MAT.0000000000002623
ER -